Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

Mild cognitive impairment (PD-MCI) and dementia (PDD) are among the most frequent non-
motor symptoms in Parkinson's disease (PD). PD-MCI is six times more likely than age …

Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder mainly in middle‐elderly population, which represents diverse nonmotor symptoms …

One of the most impactful non-motor manifestations of Parkinson's disease (PD) is cognitive
impairment. Cognitive decline in PD exists as a continuum, with symptoms ranging from …

Parkinson's disease (PD), the most common motor movement disorder and second most
common neurodegenerative disorder after Alzheimer's disease (AD), is often preceded by a …

Mild cognitive impairment (MCI) is a common feature in Parkinson's Disease (PD), even at
the time of diagnosis. Some levels of heterogeneity in nature and severity of cognitive …

The focus on cognitive impairment in neurodegenerative diseases, including PD, is shifting
from the dementia stage to earlier stages of impairment, including mild cognitive impairment …

Cognitive dysfunction is common in Parkinson disease (PD) and exists on a continuum of
severity; prevalence increases with the duration of the movement disorder. When severe …

ABSTRACT BACKGROUND Parkinson's disease is the second most common
neurodegenerative condition and associated with increasing cognitive dysfunction as the …